Skip to main content
. 2014 Feb;39(100):34–50. doi: 10.1016/j.neubiorev.2013.12.004

Table 3.

Results of the overall volumes meta-analyses.

Volume aStudies bGroups N (Fc) Analysis type Q I2 Outcome Cohen's d Percentage difference dMean difference CI 95% p-Value
ICV 77 100 14,957 (48%) FFX 62.3 0 M > F 3.03 12% 135.3 117.8–152.8 <10−6
TBV 31 40 2532 (50%) RFX 92.8 57.9 M > F 2.1 10.8% 131 92.1–170.0 <10−6
Cb 22 24 1851 (54%) FFX 12.5 0 M > F 3.35 9.8% 51.06 38.7–63.5 <10−6
GM 60 71 7934 (52%) FFX 26.5 0 M > F 2.13 9.4% 56.51 44.2–68.9 <10−6
WM 57 69 7515 (52%) FFX 39.9 0 M > F 2.06 12.9% 44.4 34.2–54.6 <10−6
CSF 35 45 4484 (50%) FFX 15.5 0 M > F 1.21 11.5% 18.72 9.6–27.8 3.2 × 10−5*
Cbl 19 26 1842 (51%) FFX 9.7 0 M > F 1.68 8.6% 7.78 4.2–11.4 1.4 × 10−5*

Abbreviations: Cb, cerebrum; Cbl, cerebellum; CSF, cerebrospinal fluid; F, females; FFX, fixed effects model; GM, grey matter; I2, I2 index; ICV, intracranial volume; N, number of subjects; Q, Cochran's Q test; RFX, random effects model; TBV, total brain volume; WM, white matter.

a

Number of studies reporting the respective volumes.

b

Number of age-matched gender groups in the analysis (some studies provide more than one sample).

c

Number of females in percentages.

d

Values reported in mL.